Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential (2021)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.72187
Publication URI: https://www.repository.cam.ac.uk/handle/1810/324736
Type: Other